A new study finds that a rising number of premature deaths prevent many Americans from reaching the age of Medicare eligibility. From 2012 to 2022, deaths among adults ages 18 to 64 increased by 27%, according to an analysis of federal mortality data from all 50 states.

A new study found that a rising number of premature deaths prevent many Americans from reaching the age of Medicare eligibility. From 2012 to 2022, deaths among adults ages 18 to 64 increased by 27%, according to an analysis of federal mortality data from all 50 states.

About The Study: Between 2012 and 2022, premature mortality among adults ages 18 to 64 in the U.S. increased by over 27%. During this period, racial disparities in premature mortality widened substantially, with Black individuals experiencing persistently higher and worsening rates compared with white individuals across most states. These results raise concerns about structural inequities within the Medicare entitlement and financing system. Despite contributing to Medicare throughout their working lives, Black individuals in the U.S. are less likely to live long enough to reach the qualifying age for coverage.

About The Study: In this case series, nonoptimal temperatures were critical environmental contributors associated with mortality burden, with differential vulnerability by geographic location, cause of death, and demographic factors. These findings highlight the need for urgent actions against temperature-related health burdens through tailored climate and public health strategies, considering the local context and demographic profiles. 

Three multi-year NIH grants to the School of Dentistry at UT Health San Antonio totaling $6 million propose new targets to stem oral squamous cell carcinoma and novel approaches to treat oral mucositis and pain.

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.